| Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma (NCT05739942) | Novartis Pharmaceuticals | 2024-05-15 |
| Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells (NCT06435897) | Shenzhen Geno-Immune Medical Institute | 2024-05-15 |
| Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma (NCT06364956) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-05-15 |
| A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants (NCT06309394) | Incyte Corporation | 2024-05-15 |
| A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy (NCT06055439) | Chimeric Therapeutics | 2024-05-15 |
| A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE) (NCT06340490) | Guangdong Ruishun Biotech Co., Ltd | 2024-05-15 |
| Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma (NCT05919238) | Impact Biotech Ltd | 2024-05-15 |
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome (NCT05419492) | Encoded Therapeutics | 2024-05-14 |
| Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers (NCT06443710) | Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | 2024-05-14 |
| Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg (NCT06553924) | Humanis Saglık Anonim Sirketi | 2024-05-14 |
| Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers (NCT06024421) | Institut National de la Santé Et de la Recherche Médicale, France | 2024-05-14 |
| Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. (NCT06762431) | Vitebsk Regional Clinical Cancer Centre | 2024-05-14 |
| Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (NCT06391775) | Genmab | 2024-05-14 |
| Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer (NCT06253494) | National Cancer Institute (NCI) | 2024-05-14 |
| Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway (NCT06287463) | Deciphera Pharmaceuticals, LLC | 2024-05-14 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants. (NCT06414798) | AbbVie | 2024-05-13 |
| A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF) (NCT06245941) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-05-13 |
| A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors (NCT06417554) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-05-13 |
| Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC (NCT05950139) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-05-13 |
| Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies (NCT06408194) | Stanford University | 2024-05-13 |
| the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human (NCT06490263) | Beijing Wehand-Bio Pharmaceutical Co., Ltd | 2024-05-13 |
| Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2) (NCT06545136) | Spur Therapeutics | 2024-05-13 |
| A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin (NCT06327880) | Pfizer | 2024-05-13 |
| Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2). (NCT06406400) | AstraZeneca | 2024-05-13 |
| A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects (NCT06857799) | Peking University First Hospital | 2024-05-13 |
| A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. (NCT06673641) | Sun Pharmaceutical Industries, Inc. | 2024-05-13 |
| A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (NCT06395519) | 858 Therapeutics, Inc. | 2024-05-13 |
| Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer (NCT06454383) | City of Hope Medical Center | 2024-05-13 |
| Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA) (NCT06222034) | Alfasigma S.p.A. | 2024-05-13 |
| Ketogenic Diet Improves Thrombocytopenia in Cancer Patients (NCT06106139) | Baoling Guo | 2024-05-12 |
| Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma (NCT06429150) | Shenzhen Geno-Immune Medical Institute | 2024-05-11 |
| An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia (NCT06308159) | Lantu Biopharma | 2024-05-11 |
| Engineered Dendritic Cell Vaccines for Multiple Myeloma (NCT06435910) | Shenzhen Geno-Immune Medical Institute | 2024-05-11 |
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients (NCT06421831) | GeneCradle Inc | 2024-05-10 |
| A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor (NCT06239298) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-05-10 |
| Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy (NCT06387186) | Elizabeth Anne Thiele | 2024-05-10 |
| Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder (NCT06557902) | Intra-Cellular Therapies, Inc. | 2024-05-10 |
| A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ) (NCT06415461) | University of Florida | 2024-05-10 |
| Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg (NCT06553937) | Humanis Saglık Anonim Sirketi | 2024-05-10 |
| Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers (NCT06339788) | Handok Inc. | 2024-05-10 |
| A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017 (NCT06388551) | Luye Pharma Group Ltd. | 2024-05-10 |
| A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) (NCT06349473) | Equilibra Bioscience LLC | 2024-05-10 |
| A Phase I Study of TRN501 in Healthy Volunteers (NCT06453551) | SNLD, Ltd. | 2024-05-10 |
| GPC3/Mesothelin-CAR-γδT Cells Against Cancers (NCT06196294) | Second Affiliated Hospital of Guangzhou Medical University | 2024-05-10 |
| A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants (NCT06366243) | Cerevel Therapeutics, LLC | 2024-05-10 |
| Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD (NCT06719596) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-05-10 |
| Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT06395870) | Tianjin Medical University Cancer Institute and Hospital | 2024-05-09 |
| A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants (NCT06363383) | Mage Biologics | 2024-05-09 |
| Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors (NCT06425926) | Georgiamune Inc | 2024-05-09 |
| A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. (NCT06298058) | Shanghai Institute Of Biological Products | 2024-05-09 |
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (NCT06283212) | Encoded Therapeutics | 2024-05-09 |
| Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients (NCT05703971) | Genprex, Inc. | 2024-05-09 |
| Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion (NCT06546397) | Women's Hospital School Of Medicine Zhejiang University | 2024-05-09 |
| A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults (NCT06394167) | Vertex Pharmaceuticals Incorporated | 2024-05-09 |
| A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination (NCT06448364) | Pfizer | 2024-05-09 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults (NCT06360874) | Shenzhen NewDEL Biotech, Co., Ltd | 2024-05-09 |
| Vertical Ridge Augmentation Using Computer-guided Sandwich Osteotomy Technique (NCT07028606) | Al-Azhar University | 2024-05-09 |
| A Phase 1 Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy Participants (NCT06406348) | AbbVie | 2024-05-09 |
| CAR-T Cell Therapy for Desensitization in Kidney Transplantation (NCT06056102) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-05-09 |
| Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML (NCT05986240) | Montefiore Medical Center | 2024-05-08 |
| Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years (NCT06216093) | EuBiologics Co.,Ltd | 2024-05-08 |
| A Study of GZR4 Injection at Different Injection Sites (NCT06548906) | Gan and Lee Pharmaceuticals, USA | 2024-05-08 |
| Apremilast for Alcohol Use Disorder Treatment in Women and Men (NCT06324435) | Yale University | 2024-05-08 |
| A Bioavailability Study of Two Different PEG-rhGH Preparations. (NCT06385145) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2024-05-08 |
| A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors (NCT06431243) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2024-05-08 |
| Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors (NCT06195384) | Second Affiliated Hospital of Guangzhou Medical University | 2024-05-08 |
| A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) (NCT05849480) | National Cancer Institute (NCI) | 2024-05-08 |
| A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors (NCT06376136) | Bio-Thera Solutions | 2024-05-08 |
| A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (NCT06258304) | GigaGen, Inc. | 2024-05-08 |
| PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia (NCT05295784) | University of Arkansas | 2024-05-08 |
| Treatment Targets in Spanish and English Bilingual Speech Intervention (NCT06416306) | Philip Combiths | 2024-05-08 |
| NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL (NCT06276101) | Newish Technology (Beijing) Co., Ltd. | 2024-05-07 |
| A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females (NCT06380205) | Incyte Corporation | 2024-05-07 |
| Acute Effects of Paraxanthine on Energy and Focus (NCT06628596) | Iovate Health Sciences International Inc | 2024-05-07 |
| Subcutaneous Administration of MD-18 in Healthy Subjects (NCT06259903) | Cohen Global, Ltd. | 2024-05-07 |
| Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation (NCT06008808) | Washington University School of Medicine | 2024-05-07 |
| A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors (NCT06215846) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2024-05-07 |
| Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa (NCT06713434) | Fundación DEBRA Chile, Niños Piel de Cristal | 2024-05-07 |
| A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily (NCT06391177) | Phathom Pharmaceuticals, Inc. | 2024-05-07 |
| Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets (NCT06193044) | International Bio service | 2024-05-07 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment (NCT06380153) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2024-05-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients (NCT06385964) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-05-07 |
| AMT-116 in Patients with Solid Tumors (NCT06782334) | Multitude Therapeutics Inc. | 2024-05-07 |
| Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (NCT06306014) | Hospices Civils de Lyon | 2024-05-07 |
| A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors (NCT06548217) | Ono Pharmaceutical Co., Ltd. | 2024-05-07 |
| A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants (NCT06412926) | Bayer | 2024-05-07 |
| IL-2 Plus Abatacept in FTD (NCT06395038) | The Methodist Hospital Research Institute | 2024-05-06 |
| Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes (NCT06403761) | Novo Nordisk A/S | 2024-05-06 |
| A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men (NCT06232252) | Boehringer Ingelheim | 2024-05-06 |
| Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus (NCT06615700) | Biomed Industries, Inc. | 2024-05-06 |
| A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects (NCT06449703) | Tonghua Dongbao Pharmaceutical Co.,Ltd | 2024-05-06 |
| A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites (NCT06415500) | Anhui Provincial Hospital | 2024-05-06 |
| A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) (NCT06138639) | Solid Biosciences Inc. | 2024-05-06 |
| Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets (NCT06248112) | Bio-innova Co., Ltd | 2024-05-06 |
| A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (NCT05973487) | TScan Therapeutics, Inc. | 2024-05-06 |
| A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants (NCT06370728) | Eli Lilly and Company | 2024-05-06 |
| A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems (NCT06272058) | Boehringer Ingelheim | 2024-05-03 |
| Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (NCT06161415) | Quan Dong Nguyen | 2024-05-03 |
| Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma (NCT06029309) | Alvaro Alencar, MD | 2024-05-03 |
| A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food (NCT06369454) | Pfizer | 2024-05-03 |